Idiopathic or cryptogenic familial epilepsy syndrome with identified loci/genes

Idiopathic or cryptogenic familial epilepsy syndrome with identified loci/genes is a broad grouping category used by Orphanet to classify inherited epilepsy syndromes in which specific genetic loci or causative genes have been identified, but the underlying mechanism by which seizures arise does not involve a structural brain lesion or known metabolic disorder. The term 'idiopathic' refers to epilepsies presumed to have a genetic basis, while 'cryptogenic' indicates cases where a cause is suspected but not yet fully elucidated. These syndromes primarily affect the central nervous system, with recurrent unprovoked seizures as the hallmark clinical feature. Seizure types may vary widely depending on the specific syndrome and gene involved, ranging from generalized tonic-clonic seizures to absence seizures, myoclonic jerks, or focal seizures. This category encompasses multiple distinct familial epilepsy syndromes, including but not limited to benign familial neonatal seizures (linked to KCNQ2 and KCNQ3), benign familial infantile seizures (linked to PRRT2 and SCN2A), generalized epilepsy with febrile seizures plus (GEFS+, linked to SCN1A, SCN1B, GABRG2), and autosomal dominant nocturnal frontal lobe epilepsy (linked to CHRNA4, CHRNB2, CHRNA2), among others. Affected individuals typically have a family history of epilepsy, and neurological examination and brain imaging are often normal between seizure episodes. Cognitive development is usually preserved, though some syndromes may be associated with mild intellectual difficulties. Treatment generally involves antiseizure medications tailored to the specific seizure type and syndrome. Many patients respond well to standard antiepileptic drugs such as carbamazepine, valproate, or levetiracetam, though treatment response can vary by genotype. Genetic testing is increasingly important for guiding therapy, as certain genetic variants may predict response or resistance to specific medications. Prognosis is generally favorable for many of these familial epilepsy syndromes, with some showing age-dependent remission, though outcomes depend on the specific underlying genetic cause.

Common questions about Idiopathic or cryptogenic familial epilepsy syndrome with identified loci/genes